Company
Headquarters: Wan Chai, Hong Kong
Employees: 4,282
CEO: Dr. Weicheng Guo
HK$5.22 Billion
HKD as of July 1, 2024
US$668.5 Million
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People's Republic of China. The company offers cardio-cerebral vascular system, digestive system, metabolism, anti-infective, respiratory, neurology, and other drugs. It also engages in the marketing of pharmaceutical products; manufacture of pharmaceutical materials and medical instruments; project preparation for the manufacture of pharmaceutical products; promotion of technology, biotechnology, and consulting services; and construction of medical projects, as well as the provision of information support, research and development, business and development, and general hospital and hospital management services. In addition, the company invests in property; constructs environmental protection projects; and wholesales chemical raw materials and medical devices. The company was founded in 2001 and is based in Wanchai, Hong Kong.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Sihuan Pharmaceutical Holdings Group Ltd has the following listings and related stock indices.
Stock: HKEX: 0460 wb_incandescent
Stock: FSX: TEL1 wb_incandescent